期刊文献+

凋亡及血管生成因子在肝细胞肝癌中的表达及意义 被引量:7

Expression and clinical significance of certain apoptosis and angiogenesis factors in hepatocellular carcinoma
原文传递
导出
摘要 目的研究部分凋亡及血管生成因子在肝细胞肝癌(肝癌)中的表达及其临床意义。方法应用免疫组化方法检测90例肝癌标本中p53、Survivin、基质金属蛋白酶(MMP)-2、MMP-9及血管内皮生长因子(VEGF)的表达情况,并分析其与肝癌术后复发的关系。结果p53、Survivin、MMP-2、MMP-9及VEGF的阳性率分别为33·3%、51·1%、60·0%、37·8%及76·7%。经相关性分析,VEGF与MMP-2、VEGF与MMP-9的表达呈正相关;MMP-2、MMP-9及VEGF与术后复发呈正相关(P<0·05)。MMP-2阴性组的1、2、3年无瘤生存率分别显著高于MMP-2阳性组中的相应指标(P<0·05),MMP-9和VEGF中亦发现类似结果。多因素分析发现术前播散结节、镜下微转移灶、血清甲胎蛋白水平以及VEGF和MMP-9的表达水平是肝癌术后复发的独立危险因素。结论p53和Survivin与肝癌术后复发无关;MMPs和VEGF与肝癌术后复发相关,可用于评价术后复发风险。 Objective To investigate the expression and clinical significance of some apoptosis and angiogenesis factors in hepatocellular carcinoma ( HCC ). Methods The expression of p53, Survivin, matrix metalloproteinases(MMP) -2, MMP-9 and vascular endothelial growth factor(VEGF) in 90 specimens of HCC was detected by immunohistochemistry. Correlations of the factors to the recurrence of HCC after hepatectomy were analyzed. Results The positive rate of p53, Survivin, MMP-2, MMP-9 and VEGF in HCC tissue was 33.3%, 51.1%, 60.0%, 37.8% and 76. 7%, respectively. Of the 5 factors, positive correlation only occurred between the expression of MMP-2 and VEGF, MMP-9 and VEGF. The expression of MMP-2, MMP-9 and VEGF was correlated to the recurrence of HCC. The 1-, 2-, and 3-year tumor-free survival rates were significantly higher in MMP-2 ( - ) group than in MMP-2 ( + ) group, and the same results were found with MMP-9 and VEGF. Multivariate analysis revealed that macroscopically disseminated nodules, tumor micrometastasis, serum alpha fetal protein (AFP) level, the expression of MMP-9 and VEGF were independent recurrence risk factors in HCC. Conclusions Neither p53 nor Survivin is correlated to the recurrence of HCC; MMPs and VEGF are correlated to the recurrence, and can be used to estimate the risk of postoperative recurrence of HCC.
出处 《中华外科杂志》 CAS CSCD 北大核心 2006年第23期1626-1630,共5页 Chinese Journal of Surgery
基金 国家"十五"攻关计划资助项目(2001BA703B054) 广东省科技计划资助项目[粤科社(2002)254] 广州市科技攻关计划资助项目(2005Z3-E0111)
关键词 肝细胞 复发 凋亡 血管生成 Carcinoma, hepatocellular Recurrence Apoptosis Angiogenesis
  • 相关文献

参考文献4

二级参考文献26

  • 1Jun Cui,Dong Hua Yang,Xiang Jun Bi,Zi Rong Fan Department of Gastroenterology, Zhujiang Hospital, The First Military Medical University, Guangzhou 510282, Guangdong Province, China.Methylation status of c-fms oncogene in HCC and its relationship with clinical pathology[J].World Journal of Gastroenterology,2001,7(1):136-139. 被引量:16
  • 2Qing Wang~1 Zhi Ying Lin~2 Xiao Li Feng~3 ~1Department of Microbiology,Medical Center of Fudan University.the former Shanghai Medical University,Shanghai 200032,China ~2Liver Cancer Institute,Zhongshan Hospital,Shanghai 200032,China ~3Shanghai Institute of Biochemistry,Academy Sinica,Shanghai 200031,ChinaQing Wang earned master degree from Shanghai Medical University in 1996,now a senior lecturer of microbiology,specialized in the role of oncogcncs on tumor metastasis,having 8 papers published..Alterations in metastatic properties of hepatocellular carcinoma cell following H-ras oncogene transfection[J].World Journal of Gastroenterology,2001,7(3):335-339. 被引量:48
  • 3Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量:214
  • 4Maija H Zile.Abnormal β-catenin gene expression with invasiveness of primary hepatocellular carcinoma in China[J].World Journal of Gastroenterology,2001,7(4):542-546. 被引量:22
  • 5W.Michael Korn Division of Gastroenterology and Comprehensive Cancer Canter,University of California San Francisco,San Francisco,CA 94143-0128,USA.Moving toward an understanding of the metastatic process in hepatocellular carcinoma[J].World Journal of Gastroenterology,2001,7(6):777-778. 被引量:13
  • 6Yamada K, Izaki K, Sugimoto K, et al. Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys, 2003,57:113-119.
  • 7Cedrone A, Rapaccini GL, Pompili M,et al. Portal vein thrombosis complicating hepatocellular carcinoma. Value of ultrasound-guided fine-needle biopsy of the thrombus in the therapeutic management.Liver, 1996,16:94-98.
  • 8Fong Y, Sun RL, Jarnagin W, et al. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg, 1999,229:790-799.
  • 9Giannelli G, Pierri F, Trerotoli P, et al. Occurrence of portal vein tumor thrombus in hepatocellular carcinoma affects prognosis and survival. A retrospective clinical study of 150 cases. Hepatol Res,2002,24:50-59.
  • 10Ohkubo T, Yamamoto J, Sugawara Y, et al. Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis. J Am Coll Surg, 2000, 191:657-660.

共引文献219

同被引文献46

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部